Finished

Evaluation of the Safety and Effectiveness of the CorPath 200 System in Percutaneous Coronary Interventions (PCI)

NCT01275092 · Siemens Healthineers Endovascular Robotics, Inc. · Updated 8 Aug 2013

What is being tested: CorPath robotic-assisted PCI
For: Coronary Artery Disease; Coronary Disease; Myocardial Ischemia; Heart Diseases; Cardiovascular Diseases; Arteriosclerosis; Arterial Occlusive Diseases; Vascular Diseases
Kind of study: Tests a treatment or device on volunteers. Phase 2.
Who can join: Ages 18 years and older. About 164 people. The full rules are on the registry page.
Where: United States, Colombia (9 sites)
When: Starts or started Jan 2011, ends Jan 2012. Registered 12 Jan 2011.
Results: Posted on the registry on 8 Aug 2013.

In the researchers' words

The objective of this study is to evaluate the safety and effectiveness of the clinical and technical performance of the CorPath® 200 System in the delivery and manipulation of coronary guidewires and stent/balloon systems for use in percutaneous coronary interventions (PCI).

ClinicalTrials.gov, NCT01275092

Sites

Washington Hospital CenterWashington D.C., District of Columbia, United States
Northeast Georgia Heart CenterGainesville, Georgia, United States
St. Elizabeth's Medical CenterBoston, Massachusetts, United States
Columbia University Medical CenterNew York, New York, United States
Saint Joseph's HospitalSyracuse, New York, United States
Wellmont CVA Heart InstituteKingsport, Tennessee, United States
Virginia Commonwealth UniversityRichmond, Virginia, United States
Swedish Medical CenterSeattle, Washington, United States
CORBICMedellín, Colombia